USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Shares of Usana Health Sciences (NYSE:USNA) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 17.89% year over year to $1.45, which missed the estimate of $1.48.

Recap: Usana Health Sciences Q1 Earnings

SALT LAKE CITY, April 26, 2021 /PRNewswire/ -- USANA Health Sciences, a global leader in nutrition, recently received three major awards from the direct selling industry's top publication, Direct Selling News (DSN) . USANA CEO Kevin Guest earned the coveted Bravo Leadership award for his success as a leader both of the company and on behalf of the entire direct selling industry.

Direct Selling News honors USANA and its CEO with three major awards

SALT LAKE CITY, April 22, 2021 /PRNewswire/ -- Earth Day is our yearly reminder that we only have one planet, and caring for it is our ultimate responsibility. USANA's view is that nurturing people is an important part of taking care of the Earth itself.

USANA's Environmental, Social, and Governance initiative aims to make a positive, lasting impact for the earth and the USANA Family

BJ`s Wholesale Club Holdings Inc

Coca-Cola Bottling

Campbell Soup

Fidelity MSCI Consumer Staples ETF

Kroger

Nu Skin Enterprises

Sally Beauty Hlds

Seneca Foods

Sprouts Farmers Markets

Target

A dashboard with metrics in consumer non-cyclical industries. Value and quality scores, and their evolution since last month.

Consumer Staples And FSTA Dashboard For April

SALT LAKE CITY, April 13, 2021 /PRNewswire/ -- Identifying a mentor for perspective and guidance is a key to securing solid footing in uncertain times, according to a global author and CEO. "One of the undisputed secrets to my success has been following advice from mentors," said Kevin Guest, author of the bestseller, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony.

Seek Mentor in Pandemic, Global Author/CEO Says

SALT LAKE CITY, April 7, 2021 /PRNewswire/ -- USANA, the Cellular Nutrition Company, provides its high-quality, NSF-tested nutritional products to more professional and elite athletes than any other nutritional supplement company in the world. Proudly supporting athletes in nearly two dozen countries, the Utah-based company is expanding its presence in the United States as the Official Multivitamin of USA Swimming, the national governing body for the sport of swimming in the U.S. "We are honored to have the opportunity to partner with an accomplished organization like USA Swimming," says Dan Macuga , chief communications and marketing officer at USANA.

USANA Dives Into Partnership With USA Swimming

Griffon

Lithia Motors

Sleep Number

According to the Buffett-Munger Model Portfolio, four stocks with strong gains during the first quarter that align with Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B) co-managers Warren Buffett (Trades, Portfolio) and Charlie Munger (Trades, Portfolio)'s investing strategy are Sleep Number Corp. (NASDAQ:SNBR), Lithia Motors Inc. (NYSE:LAD), Usana Health Sciences Inc. (NYSE:USNA) and Griffon Corp. (NYSE:GFF).

4 Buffett-Munger Stocks With Strong Gains as of the 1st Quarter

Home Depot

IDEXX Laboratories

Moody's

In light of the Federal Reserve's announcement that it will pause interest rate hikes through 2023, investors may want to have a look at these four good companies that have strong Piotroski F-scores according to the All-in-One Screener, a Premium feature of GuruFocus: The Home Depot Inc. (NYSE:HD), IDEXX Laboratories Inc. (NASDAQ:IDXX), Moody's Corporation (NYSE:MCO) and Usana Health Sciences Inc. (NYSE:USNA).

4 Good Companies with High Piotroski F-scores

SALT LAKE CITY, March 17, 2021 /PRNewswire/ -- Applying the new 3Rs, resilience, recalibration and relationships, will help today's workers get through challenges brought by the pandemic, according to a global author and CEO. "The first thing to acknowledge is that every person who has made it this far through the pandemic is resilient, and that is a key strength that is going to carry us through to even greater heights," said Kevin Guest, author of the bestseller, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony.

Applying New 3Rs Gets Workers through Pandemic, Global Author/CEO Says

USANA Health (USNA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

USANA Health (USNA) Soars to 52-Week High, Time to Cash Out?

SALT LAKE CITY, Feb. 25, 2021 /PRNewswire/ -- USANA extends a tremendous congratulations to Teresa Elias, executive director of digital and brand strategy, for being named one of Utah Business Magazine's 40 under 40. Teresa was honored at an awards ceremony yesterday, along with other...

USANA executive director recognized as a top young leader in Utah

SALT LAKE CITY--(BUSINESS WIRE)--USANA (NYSE: USNA), USANA Health Sciences, Inc. today announced that its Board of Directors has formed a Sustainability Committee to oversee and advise on all matters related to corporate sustainability, including environmental, social and governance (ESG) and corporate social responsibility (CSR) matters. The Sustainability Committee was formed to ensure that USANA's business strategies and activities remain aligned with important matters related to sustainabil

USANA Announces Formation of Board Sustainability Committee

USANA Health Sciences (USNA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: USANA Health Sciences (USNA)

Oncternal Therapeutics Inc

Organogenesis Holdings

Schnitzer Steel Industries Inc

Turning Point Therapeutics

5 Small Drug Stocks to Buy Amid Lingering COVID-Led Uncertainty

Catalent

USNA vs. CTLT: Which Stock Is the Better Value Option?

USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q4 2020 Results - Earnings Call Transcript

AbCellera Biologics

AzurRx BioPharma

Cancer Genetics

Usana Health Sciences (NYSE: USNA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued fiscal year 2021 EPS and sales guidance above estimates. The company also announced a $150 million buyback.

Why AzurRx BioPharma, Usana Health Are Moving Today

USANA Health (USNA) delivered earnings and revenue surprises of 34.53% and 8.31%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates

Shares of Usana Health Sciences (NYSE:USNA) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 32.62% year over year to $1.87, which beat the estimate of $1.43.

Recap: Usana Health Sciences Q4 Earnings

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full-year ended January 2, 2021. Key Q4 and Full Year 2020 Financial & Operating Highlights Fourth quarter net sales increased 14.5% year-over-year to $310.5 million. Fourth quarter diluted EPS increased 32.6% year-over-year to a record $1.87. Fiscal year net sales increased 7.0% year-over-year to $1.135 billion. Fiscal year diluted EPS increased 32.9

USANA Health Sciences Finishes Strong 2020 with 14.5% Fourth Quarter Net Sales Growth and 32.6% Diluted EPS Growth

Usana Health Sciences (NYSE:USNA) announces its next round of earnings this Tuesday, February 09. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement.

Usana Health Sciences Earnings Preview

Celsius Holdings

Herbalife

The stock market is in full-bull mode in recent months, driven by massive monetary and fiscal stimulus, outperforming economic data, a de-escalation in political tension, extraordinary strides on the pandemic vaccine front, and, perhaps most importantly, the emergence of enthusiastic participation from mom & pop retail investors. As that process has played out with increasing […]

The Nutrition Supplement Growth Theme Heats Up (NYSE: USNA) (NYSE: HLF) (OTC US: TQLB) (NASDAQ: CELH)

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter results will be released after the close of market Tuesday, February 9, 2021. Shortly following the issuance of the Company's earnings release, the Company will post a “Management Commentary, Results and Outlook” document on the Company's website (http://ir.usana.com) under the “Investor Relations” section of the site. The following morning at 11:00 a.m. Eastern Time, USANA will hold a c

USANA Schedules Fourth Quarter Earnings Release and Conference Call

SALT LAKE CITY, Jan. 5, 2021 /PRNewswire/ -- USANA (NYSE: USNA), a leader in cellular nutrition, ended 2020 on a high note with two major awards. The company recently won the DSA Product Innovation award for its Oral Care product line, and Executive Director of Marketing and Social Media...

USANA Closes Out 2020 with Two Prestigious Awards

SALT LAKE CITY, Dec. 30, 2020 /PRNewswire/ -- USANA, a leader in cellular nutrition, has once again been recognized with a seal of approval by renowned, third-party assessor ConsumerLab.com—this time for its omega-3 supplement, BiOmega. This ultrapure fish-oil supplement supports...

News for USANA Health Sciences Stock (USNA)